Severe itching (22%), sensitivity to sunlight (5%), and rash (25%) are some of the common adverse effects of<unk> . Other side effects may include nausea, muscle pain, difficulty breathing and increased bilirubin. It may reactivate hepatitis B in those who have been previously infected. The European Medicines Agency (EMA) has recommended screening all people for hepatitis B before starting<unk>  for hepatitis C in order to minimize the risk of hepatitis B reactivation. Combination treatment In March 2015, Gilead Sciences e-mailed warnings to health care providers about nine people that began taking its hepatitis C drugs ledipasvir/sofosbuvir or sofosbuvir along with amiodarone, daclatasvir, or<unk>  developed abnormally slow heartbeats and one died of cardiac arrest. Three required a pacemaker to be inserted. Gilead said the combinations aren't recommended and product labels will be updated.
Simeprevir
Saquinavir
Telaprevir
Fosamprenavir
Glecaprevir
Abacavir
Indinavir
Fostemsavir